4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-004419
Director sold 300,000 shares at an average $4.67 ($1,400,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Noble James Director | 2020-01-13 | Sale | −100,000 | $4.00 | $400,000 | 0 | D |
| Noble James Director | 2020-01-13 | Sale | −200,000 | $5.00 | $1,000,000 | 0 | D |
| Open-market sales · 300,000 sh · avg $4.67 · $1,400,000 | |||||||
Loading xslF345X03/a4.xml…